Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
BBH
27
HOLDINGS
50%
ALSO IN PBE
PBE
28
HOLDINGS
43%
ALSO IN BBH
SECTOR DRIFT (BBH minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 9.6% | 4.9% | 4.9% |
|
AMGEN INC | 17.1% | 4.8% | 4.8% |
|
REGENERON PHARMACEUTICALS | 7.5% | 4.8% | 4.8% |
|
GILEAD SCIENCES INC | 16.7% | 4.6% | 4.6% |
|
BIOGEN IDEC INC | 3.3% | 5.5% | 3.3% |
BBH Overweight Relative to PBE
|
AMGEN INC | 12.3% |
|
GILEAD SCIENCES INC | 12.1% |
|
VERTEX PHARMACEUTICALS INC | 4.7% |
 |
ARGENX SE ADR | 4.1% |
|
NATERA INC | 3.7% |
|
ALNYLAM PHARMACEUTICALS INC | 3.5% |
|
IQVIA HOLDINGS INC | 3.5% |
|
INSMED INC | 3.4% |
|
BEIGENE LTD. SPONSORED ADR | 3.2% |
|
MODERNA, INC. | 2.8% |
BBH Underweight Relative to PBE
|
ROYALTY PHARMA PLC CLASS A | -4.7% |
|
IONIS PHARMACEUTICALS, INC. | -4.2% |
|
PTC THERAPEUTICS INC | -3.4% |
|
SAREPTA THERAPEUTICS INC | -3.2% |
|
VERACYTE INC | -3.2% |
|
INCYTE CORP | -2.9% |
|
EXELIXIS INC | -2.7% |
|
CATALYST PHARMACEUTICAL PART | -2.7% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.7% |
|
DYNAVAX TECHNOLOGIES CORP | -2.5% |